UNSPSC 51453004: Piperazine calcium edetate

This classification denotes an antihelminthic agent "C10H12N2O8.C4H10N2.2""H+"".Ca", a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L4QEN8344Z, chemically known as calciate(2-), ((n,n'-1,2-ethanediylbis(n-(carboxymethyl)glycinato))(4-)-n,n',o,o',on,on')-, (oc-6-21)-, dihydrogen, compd. with piperazine (1:1), but more generally known as piperazine calcium edetate, which bears US NIH Compound Identifier 23724991.

European Medicines Agency schedules Piperazine calcium edetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09869MIG. Most nations, for tariff and trade purposes, schedule piperazine calcium edetate under HS 29335990 and SITC 51576. SMILES: As of Q4 2014, PIPERAZINE CALCIUM EDETATE remains US FDA's Preferred Term for this commodity.

UNSPSC 51453004 Piperazine calcium edetate is a Commodity code that nominally addresses a pharmaceutical chelation agent, but recent state and local procurement activity under this code shows a substantial mismatch: the opportunities posted are for naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription programs. None of these solicitations involve piperazine calcium edetate or chelation therapy. The code appears to capture a narrow pharmaceutical ingredient with limited current demand in state and local government contracting, and the opportunities recorded under it do not reflect the code's nominal scope. State and local health and emergency-services agencies are the primary issuing bodies when activity does appear, including county health departments, state HHS commissions, municipal fire departments, and multi-state cooperative purchasing alliances.

Geographic activity when present spans Florida (Seminole County), Texas (HHS Commission), Florida (City of Tampa), and multi-state cooperative programs (Minnesota MMCAP serving Minnesota and Oregon). Representative recent solicitations include Seminole County, Florida's IFB for naloxone and drug deactivation systems (due July 26, 2023, seeking 1,900 units of naloxone and 800 deactivation systems annually), the City of Tampa's IFB for medical and first aid supplies to the Tampa Fire Department Rescue Division (due March 13, 2026, estimated contract value $700,000, designated as sheltered for certified Small Local Business Enterprises with a 5 percent bid discount), and Minnesota MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026, serving participating state and local facilities across Minnesota and Oregon). The code shows no meaningful recent procurement activity aligned to its stated pharmaceutical purpose and may benefit from reclassification or realignment with actual state and local pharmaceutical purchasing patterns.